PBMC and Flow Cytometry in Immunotherapy Development

Key Flow Cytometry Markers Assessed Across Multiple Disease Categories

Key Flow Cytometry Markers Assessed Across Multiple Disease Categories Flow cytometry is an invaluable tool for multidimensional cellular analysis and continues to expand its applications in clinical research. At MLM Medical Labs, each assay is tailored to the therapeutic area, leveraging advanced markers and techniques. Below are key markers that can be assessed across multiple […]

Key Flow Cytometry Markers Assessed Across Multiple Disease Categories Read More »

PBMC and Flow Cytometry in Immunotherapy Development

PBMCs and Flow Cytometry: Unlocking T-Cell Activation Insights for Immunotherapy Development

At MLM Medical Labs, PBMC isolations and flow cytometry succcessfully work hand-in-hand in drug discovery and development, particularly in immunology and immunotherapy research.  Following is a real-world example: PBMCs and Flow Cytometry : Evaluating T-Cell Activation in Immunotherapy Development Context A leading biopharma company is developing a checkpoint inhibitor targeting the PD-1/PD-L1 pathway for cancer

PBMCs and Flow Cytometry: Unlocking T-Cell Activation Insights for Immunotherapy Development Read More »

Biomarkers in Alzheimer's and Parkinson's Disease Research and Drug Discovery

Biomarkers in Alzheimer’s & Parkinson’s Disease Research

Comprehensive Biomarker Testing for Global Neurodegenerative Disease Trials At MLM Medical Labs, we bring 30 years of expertise in delivering comprehensive central and specialty lab support for complex global clinical trials, including Alzheimer’s and Parkinson’s Disease research. Cutting-Edge Biomarker Solutions for Neurodegeneration We offer a robust portfolio of neurodegeneration biomarkers, ensuring high-quality, reliable data to

Biomarkers in Alzheimer’s & Parkinson’s Disease Research Read More »

Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH More Fitting Term

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term

by Katie Dineen, B.S. Biology, Business Development Manager, Preclinical Research Lab Introduction:  Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and liver cell damage. One crucial aspect contributing to the development and progression of NASH is metabolic dysfunction.   Understanding NASH:  NASH falls under the broader category of nonalcoholic fatty liver disease (NAFLD),

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term Read More »

PBMC Isolation and Processing in Preclinical and Clinical Trial Research at MLM Medical Labs

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services

In the rapidly evolving landscape of biopharma, the need for precise, reliable, and scalable cellular resources has never been more critical. At MLM Medical Labs, we specialize in providing high-quality Peripheral Blood Mononuclear Cells (PBMCs) to support cutting-edge research and development across a variety of therapeutic areas. Why Partner with MLM?Our PBMC lab services are

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services Read More »

Leverage MLM’s Comprehensive Immunoassay Capabilities to Accelerate Your Preclinical and Clinical Trial Program

At MLM, we specialize in providing cutting-edge, fully customizable immunoassay solutions tailored to meet the complex requirements of your preclinical and clinical trial. Our state-of-the-art laboratories in Germany and the U.S. are equipped with a broad range of immunoassay technologies, allowing us to deliver high-quality, reliable data to support the development of new drugs and

Leverage MLM’s Comprehensive Immunoassay Capabilities to Accelerate Your Preclinical and Clinical Trial Program Read More »

Bleomycin-induced IPF models at MLM Medical Labs are an invaluable tool in preclinical research on IPF.

Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery

by Katie Dineen, B.S., Business Development Manager – Preclinical Research Lab 🎭 Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery 🌌  Imagine a play where the script is written in invisible ink, characters wear disguises, and the plot takes unexpected twists – that’s Idiopathic Pulmonary Fibrosis (IPF). 🎭 This lung-drama unfolds with a mysterious

Embarking on the Theatrical Saga of IPF: The Unveiling of a Pulmonary Mystery Read More »

Histology and Digital Pathology Lab at MLM Medical Labs

Advancing Biopharma Research with Precision Histology and Digital Pathology Services

At MLM, our Histology and Digital Pathology lab and experienced team of PhD-led scientists are equipped to support biopharma companies at the forefront of research into new drugs and therapies, offering specialized services tailored to meet your exacting needs. Our state-of-the-art facilities which feature the Aperio GT 450 DX automated digital pathology scanner from Leica

Advancing Biopharma Research with Precision Histology and Digital Pathology Services Read More »

Scleroderma Awareness Month

Innovating for a Brighter Future in Scleroderma Research

June marks Scleroderma Awareness Month, a crucial period dedicated to raising awareness about this challenging autoimmune disease and highlighting its profound impact on countless lives. At MLM Medical Labs, we are steadfastly committed to advancing research and supporting therapeutic initiatives to combat systemic sclerosis (SSc), a severe manifestation of scleroderma.

Innovating for a Brighter Future in Scleroderma Research Read More »